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Background: Gut flora are important immunomodulators that may be disrupted in individuals with atopic
conditions. Probiotic bacteria have been suggested as therapeutic modalities to mitigate or prevent food allergic
manifestations. We wished to investigate whether perinatal factors known to disrupt gut flora increase the risk of
IgE-mediated food allergies.
Methods: Birth records obtained from 192 healthy children and 99 children diagnosed with food allergies were
reviewed retrospectively. Data pertaining to delivery method, perinatal antibiotic exposure, neonatal nursery
environment, and maternal variables were recorded. Logistic regression analysis was used to assess the association
between variables of interest and subsequent food allergy diagnosis.
Results: Retrospective investigation did not find perinatal antibiotics, NICU admission, or cesarean section to be
associated with increased risk of food allergy diagnosis. However, associations between food allergy diagnosis and
male gender (66 vs. 33; p=0.02) were apparent in this cohort. Additionally, increasing maternal age at delivery was
significantly associated with food allergy diagnosis during childhood (OR, 1.05; 95% CI, 1.017 to 1.105; p=0.005).
Conclusions: Gut flora are potent immunomodulators, but their overall contribution to immune maturation
remains to be elucidated. Additional understanding of the interplay between immunologic, genetic, and
environmental factors underlying food allergy development need to be clarified before probiotic therapeutic
interventions can routinely be recommended for prevention or mitigation of food allergies. Such interventions may
be well-suited in male infants and in infants born to older mothers.
Keywords: Antibiotics, Atopic dermatitis, Bifidobacteria, Cesarean section, Food allergy, Group B Streptococcus,
Gut flora, Lactobacillus, PBMC peripheral blood mononuclear cellBackground
Distinct differences in intestinal microbiota have been
identified in children with atopic conditions compared to
their non-allergic peers [1]. Specifically, current evidence
suggests that decreased numbers of lactic acid-producing
bacteria and/or increased numbers of pro-inflammatory
microorganisms in the gastrointestinal tract of infants
may predispose to atopic dermatitis. During the first year
of life, fewer gastrointestinal bifidobacteria (and con-
comitantly more clostridia and Staphylococcus aureus)
have been identified in children who are diagnosed with* Correspondence: kjd136@psu.edu
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reproduction in any medium, provided the oratopic conditions [2]. Similarly, in rodent models of
atopy, Bifidobacterium and/or Lactobacillus sp. have
been found to repress cellular and humoral responsive-
ness in milk-allergic mice and even restore oral tolerance
[3,4]. Taken together, these pre-clinical and clinical
observations suggest that a critical balance of gut flora is
needed for oral tolerance and appropriate immune mat-
uration such that specific atopic manifestations can be
avoided [5,6] (Figure 1).
Probiotics are live microorganisms that provide health
benefits when ingested in adequate quantities. These
bacteriotherapies are increasingly used by consumers
and recommended by health care providers including
pharmacists and nutritionists [7-9]. Probiotics, used as
dietary supplements, have been investigated as a meanstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Depiction of gut flora contribution to atopy. The neonatal immune system (Th0) is predisposed to develop Th2 responses, especially
in the presence of atypical gut flora or the absence of lactobacilli and/or bifidobacteria. Therapies that stimulate Th1 responses may be able to
restore balance and lead to immunologic tolerance rather than hypersensitivity.
Table 1 ICD-9 codes used to identify children with food
allergies
ICD9 Code Diagnosis
558.3 Allergic gastroenteritis and colitis
693.1 Dermatitis due to food
708.9 Urticaria not otherwise specified
995.6 series Anaphylactic shock due to food
995.7 Other adverse food reactions, not specified elsewhere
V15.01 Allergy to peanut
V15.02 Allergy to milk
V15.03 Allergy to egg
V15.04 Allergy to seafood
V15.05 Allergy to food additives or other nuts
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tions, albeit with conflicting results [10-15].
Preliminary work from our laboratory suggests that
co-incubation of probiotic bacteria with peripheral blood
mononuclear cells (PBMCs) induces cytokine responses
in a manner that is consistent with responses observed
in vivo during induction of oral tolerance [16-21]. In-
deed, we find that PBMCs respond to probiotics with a
heightened release of IFN-γ, IL-10, and IL-12; further-
more, some of these effects are observed to be more
robust in cells obtained from cord blood than from adult
donor cells (Additional file 1). These results suggest that
appropriately-selected and suitably-dosed probiotic sup-
plements have potential to prevent/restore aberrant Th2
responses by shifting immunity in favor of a Th1-type
phenotype.
If appropriately selected bacterial therapies can posi-
tively impact oral tolerance mechanisms, it is likely that
these dietary supplements would mediate their greatest
effects in individuals with disrupted intestinal flora. Fac-
tors known to disrupt neonatal acquisition of gut flora
include cesarean section delivery, use of antibiotics, and
time spent in a neonatal intensive care unit (NICU)
[22-34]. We hypothesized that factors known to disturb
perinatal acquisition of gut flora would increase the risk
of subsequent food allergy diagnosis in childhood. Such
a correlation would be useful in identifying children at
greatest risk of food allergies such that appropriate
immunomodulatory interventions could be implemen-
ted. Our hypothesis was tested via a retrospective chart
review of birth records. We identified gender in chil-
dren and age of mother at time of delivery as being
associated with increased risk of food allergies in chil-
dren, but did not find associations between food aller-
gies and antibiotic exposure, delivery method, or
neonatal nursery.Methods
Retrospective chart review inclusion criteria
With approval and oversight from the Institutional
Review Board at Penn State Hershey Medical Center
(PSHMC) (IRB # 24958EP), a retrospective chart review
was undertaken to identify children visiting either (a) a
PSHMC primary care practice (controls) or (b) allergy
specialty clinic for a food allergy-related concern (cases)
who were also born at the institution’s medical center.
Penn State Hershey Children’s Hospital has more than a
million children in the referral area and offers the only
Level I pediatric trauma center in more than 70,000
square miles. Similarly, the allergy clinic is a physician-
referral clinic that sees complex patients; the catchment
area for the allergy clinic covers more than 85,000
square miles of central and eastern Pennsylvania and
accepts both private and public insurances.
To identify allergic children, the ICD-9-CM coding
system was used to identify clinic visits that were coded
in a manner consistent with food-related allergic reac-
tions (Table 1). Those codes were subsequently matched
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2000, and June 30, 2005. The children identified as a re-
sult of this match were considered to be “potential
cases”, and their medical charts were retrieved for re-
view. However, only children whose medical charts con-
firmed the presence of food allergies, documented by
either a positive serum specific IgE test, (specific IgE
antibodies >0.35 kU/L) or positive skin prick test (SPT)
(≥ 3 mm compared with negative control), were
included in our data analysis as allergic “cases”. Children
were excluded from our dataset if miscoding errors were
identified (e.g., latex allergies instead of food allergies) or
if parent reported “food allergy” that was not confirmed
by laboratory testing (e.g., parent thinks child is “aller-
gic” to milk because s/he experiences abdominal discom-
fort). In an attempt to increase our number of allergic
cases, a protocol modification was made near the con-
clusion of our chart review period that also permitted us
to accept direct referrals from pediatricians familiar with
our study objectives if they were aware of patients with
food allergies that had not been identified via billing
records (e.g., possibly missed by initial search of billing
records due to ICD-9 mis-coding).
Chart review data collection
Age- and sex-matched controls for this analysis included
children born at PSHMC, followed by our pediatric
clinics for well-visit check-ups, but without evidence of
food-mediated reactions; this cohort of children was also
identified from billing records. For both control children
and case children, data abstracted from birth records of
the child and labor/delivery records of the mother were
used to investigate perinatal factors known to impact
gut flora acquisition. Data retrieved from charts
included: delivery type, time spent in the neonatal inten-
sive care unit, evidence of atopy for child and mother
(including anaphylaxis, atopic dermatitis, hives, respira-
tory allergies), maternal group B Streptococcus status,
maternal receipt of antibiotics during delivery, maternal
intent to breastfeed, and age and parity of birth mother.
Statistical analysis
Chart review analyses were performed using a matched
case–control design where nearly every case was
matched with 2 controls. A sample size of 200 cases and
400 controls was planned. It was expected that such a
sample would provide >90% power to detect differences
between cohorts if the odds ratio was 1.8 or higher for
variables such as intrapartum antibiotic exposure where
use in the control population approximates 30%. Chi
square and Fisher exact tests were used for data analysis
using SAS version 9.2 (SAS Inc, Cary, NC). Descriptive
statistics, including mean, median, standard deviation
and quartiles for continuous measures, and frequenciesfor categorical measures were used to characterize the
case and control populations. Logistic regression analysis
was used to assess associations between variables of pri-
mary interest and food allergy. Strength of associations
is expressed using odds ratios with 95% confidence
intervals.
Results
Neonatal and birth mother retrospective chart review
Initial billing records identified 6160 children with ICD-
9-CM codes consistent with medical visits related to
food allergic reactions between 2000 and 2005 (Figure 2).
However, only 235 (3.8%) of those children were born at
PSHMC, to permit direct examination of birth records.
Of those 235 children (n=125 for males; n=110 for
females), a thorough review of medical records con-
firmed food allergies (positive IgE or SPT) in only 82
(35%) children. In an effort to increase the number of
food allergic cases, direct referrals from pediatricians
were subsequently accepted; as a result, we expanded
the age of children who could be considered as “cases”
to 18 years of age based on these direct physician refer-
rals. This protocol modification increased the number of
food allergic children (by 17) for whom we could evalu-
ate birth records to 99; three of these children were born
in 1998 or 1999. Medical records from 192 non-food
allergic children born at the same hospital were also
examined as controls. Overall, the mean age of children
at the time that charts were reviewed was 5.0 ± 1.5 years,
with a mean age of 4.8 ± 1.9 years in the allergic cohort
and 5.1 ± 1.3 years (p=0.12) in the non-allergic children.
Of the 291 children (99 cases; 192 controls) included
in our analysis, 167 were male and 124 were female
(Table 2). There was no difference in gestational age
for children with allergies versus non-allergic children
(38.3 weeks ± 2.39 weeks; range 27 to 41 weeks versus
38.0 weeks ± 2.86 weeks; range 25 to 42 weeks). There
was also no difference in birth weight between the two
groups (3.36 kg ± 0.67 kg; range 0.81 to 4.61 kg versus
3.24 kg ± 0.76 kg, range 0.66 to 5.07 kg).
Ethnicity data were available for 282 mothers: 87.6% of
mothers self-identified as white (non-Hispanic), whereas
the remaining women identified as African American
(4.3%), Asian (4.6%) or Hispanic (3.5%). For 45% of the
mothers, the children represented by these data were
firstborn. In all, 14% of mothers reported a personal his-
tory of asthma and 4% of mothers reported food aller-
gies. The likelihood of having a child diagnosed with
food allergies was slightly higher for women with a his-
tory of atopy compared to women that did not report
atopic conditions (43% versus 32%), but this did not
reach significance (OR, 1.60; 95% CI, 0.861-2.996;
p=0.14). Maternal parity was not associated with an
increased incidence of food allergies in offspring, neither
6160 children with 
ICD -9-CM codes 
consistent with a food 

















to our study by 
pediatricians
99 Food Allergic Children  
Figure 2 Identification of Allergic Cohort. HMC, Hershey Medical Center; RAST, radioallergosorbent test; SPT, skin prick test.
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cantly between mothers whose children developed food
allergies (30.68 ±5.06 years) compared to those that did
not (28.55 ± 6.48 years). However, an association was
identified between the odds of food allergy diagnosis in
childhood and maternal age at delivery (OR =1.05; 95%
CI, 1.017 to 1.105; p=0.005). For each advancing year of
maternal age at time of delivery, the odds of food aller-
gies being diagnosed in the child increased by 6.0%. This
relationship was linear for mothers whose age ranged
from under 20 years through 35 years of age (Figure 3).
In the cohort of 99 children with allergies, the mean
age at the time of allergy diagnosis was 1.5 years of age
and males were significantly more likely to be diagnosed
with a food allergy than females (OR = 1.80; 95% CI,
1.088-2.985; p=0.02). Allergies to peanuts, eggs, milk,
and other nuts were the most common, impacting 53%,
49%, 43%, and 18% of the food allergic children, respect-
ively. Forty-five percent of children with food allergies
were allergic to just one food item, with the remaining
children allergic to two or more foods. When these chil-
dren were exposed to allergenic food(s), they most often
experienced skin eruptions, including dermatitis and
hives (69%). Anaphylaxis was uncommon (n=10; 5.2%).
No differences were observed with respect to develop-
ment of food allergies and method of delivery (allergy
diagnosis in 34% delivered vaginally and 33% delivered
via cesarean; OR=0.93; 95% CI, 0.557-1.564; p=0.79),postnatal antibiotics (40% who developed allergies
received antibiotics versus 33% who did not receive anti-
microbials; OR=1.35; 95% CI, 0.680-2.677; p=0.39),
intrapartum maternal antibiotic exposure (allergy diag-
nosis in 34% of children whose mothers did or did not
receive intrapartum antibiotics; OR=1.00; 95% CI, 0.587-
1.715; p=0.998), or time spent in the NICU (allergy diag-
nosis in 34% and 35% of children who did and did not
immediately move to the well child nursery; OR=1.04;
95% CI, 0.544-1.977; p=0.91). Vaginal group B Strepto-
coccus (GBS) status was unknown in half the women; for
those mothers in whom GBS status was known to be
positive, an increased likelihood of developing food aller-
gies was not observed (OR=1.14; 95% CI, 0.556-2.348;
p=0.72). Most women (79%) expressed intent to breast-
feed their infants; however, intent to breastfeed did not
vary between mothers with a positive or negative per-
sonal history of atopy (84% versus 78%; p=0.21). A posi-
tive correlation between maternal intent to breastfeed
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atopic dermatitis have been identified [11,12,35-37].
Furthermore, physiologic evidence links atopic derma-



























Figure 3 Incidence of food allergies as a function of maternal age at
and maternal age at delivery. For each advancing year of maternal age, the
Table 2 Characteristics of food allergic and non-allergic
children whose birth records were retrospectively
reviewed










Not identified 4 6
Parity (n) 0.93
Zero (excluding this child) 79 154
≥1 (excluding this child) 20 38
Maternal History of Atopy (%) 0.15
Yes 43 57
No 32 68
Gestational age (weeks) 38.3 38.0 0.33
Birth weight (kg) 3.36 3.24 0.17
Delivery Type (%) 0.79
Vaginal 67.7 66.1
C-section 32.2 33.9
Peripartum antibiotics (%) 28.3 28.1 1.0
Neonatal antibiotics (%) 16.2 12.5 0.39
NICU stay (%) 17.2 16.7 0.91
Known positive intent to
breastfeed (%)
88.9 74.2 <0.005
Known Group B Streptococcus 0.72
Positive (%) 18 16
Negative (%) 32 33
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disrupt perinatal gut flora acquisition and subsequent
food allergy diagnosis.
We hypothesized that specific factors known to cause
gastrointestinal dysbiosis in newborns – namely peri-
natal antibiotic exposure, cesarean section delivery, and
NICU admission – are associated with subsequent food
hyper-responsiveness. However, we did not find such
correlations to be present in children with confirmed
evidence of IgE-mediated food allergies.
In our cohort, we did find, however, that increasing
maternal age at delivery is associated with food allergy
diagnosis in children. A similar relationship was recently
reported by Metsala and colleagues [39]. Although the
biologic mechanisms responsible for this association are
unclear, it is possible that disrupted maternal normal
flora may be involved. It is known that changes in nor-
mal flora occur across the lifespan from medications or
changes in gastrointestinal tract function. Specifically,
with advancing age, levels of gut bifidobacteria and
lactobacilli decrease, whereas clostridia and yeast in-
crease [40]. These same changes in gut flora have been
previously noted in children with atopy [2]. Thus, while
it has not yet been studied, there may be a critical time
point during adult life in which mothers may begin to
develop disruptions in gut flora, which may then be
transferred to children during the delivery process.
We also observed that the number of allergic males in
our cohort significantly exceeded the number of allergic
females. We are not alone in identifying these gender
disparities in atopic sensitization of children. Males have
previously been found to have food allergies and other
atopic diseases with a higher prevalence than females
during childhood and early adolescence [41-46]. Cer-
tainly, there may be genetic causes underlying this pre-
disposition, but environmental factors may also play a
role. It has been suggested that gender differences in31-35 36-40 >40
at Delivery
delivery (years). Correlation of food allergy diagnosis in childhood
odds of food allergies diagnosed in newborn increases by 6.0%.
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to breastfeed male infants for a shorter period of time
due to the misconception that male infants require a
greater level of nutrition than can be provided by breast
milk alone [47-50]. Breastfeeding has been reported to
provide protection against atopic dermatitis and/or food
allergies [51-54]. In addition to nutritive and immuno-
logical benefits, breast milk is also known to stimulate
growth of bifidobacterial populations. Thus, it is con-
ceivable that breastfeeding duration may play a role in
gut flora acquisition and subsequent atopic develop-
ment. In support of this theory, there is evidence that
male infants are indeed more likely than female infants
to experience benefits of early probiotic interventions
[55].
In our study, we found that maternal breastfeeding in-
tent at time of delivery was associated with increased
risk of food allergies. Given the retrospective nature of
our data collection and since we did not contact
mothers directly, we do not know the extent to which
maternal intent to breastfeed at time of delivery trans-
lated into initiation/duration of breastfeeding. With 79%
of mothers in our cohort indicating initial intent to
breastfeed, the observed correlation between breastfeed-
ing and food allergies in our data may be attributed to
reverse causation, as has been reported previously, since
breastfeeding intent and exclusive breastfeeding after
hospital discharge may differ considerably [56-59]. Given
the limitations imposed by retrospective data collection
regarding breast-feeding decision and duration, we can-
not draw definitive conclusions about its role in food-
allergy development in our cohort.
Although we did not find an association between food
allergies and type of delivery, maternal intrapartum re-
ceipt of antibiotics, or NICU placement, these relation-
ships warrant further study. Technical limitations were
imposed by our dependence upon the ICD-9-CM coding
system to identify children with food allergies, as this
system is an imperfect surrogate for allergy diagnosis. As
a result, we were not able to identify the number of food
allergic children that we had initially set out to include
in our dataset. When initially established, ICD-9-CM
codes were created for insurance reimbursement pur-
poses, not for research purposes. Furthermore, there
may be tendencies, on the part of clinicians, to assign
specific ICD-9-CM codes to a particular group of signs
and symptoms based on reimbursement levels. This may
explain why we initially identified 235 children with food
allergy-diagnosis-codes born at our institution, but
whose diagnosis was only substantiated (by IgE or SPT)
in 85 of them. Indeed, we observed that food allergy spe-
cific ICD-9-CM codes were used for parent-reported
food intolerances, as well as allergies to non-food items
(e.g., latex allergy). Recently, Clark et al. also observedthat exclusive reliance upon food-allergy-specific ICD-9-
CM codes to identify patients with food allergies, would
have led to a ~50% discrepancy from the true number of
patients with food hypersensitivities [60].
However, a particular strength of our data set is the
rigor with which we identified children as “cases” only if
an IgE-mediated food allergic reaction had been con-
firmed [61,62]. By focusing exclusively on children with
IgE-mediated food allergies, we may have failed to iden-
tify children with food allergic manifestations that are
mediated by non-IgE mechanisms [63,64]. Rather than
relying upon retrospective review of medical and billing
records, future investigations into the role of perinatal
and immunological factors impacting food allergies
should be initiated prospectively at birth.
Conclusion
In conclusion, in our cohort of children with IgE-
mediated food allergies, we found that males are at a
greater risk of developing food allergies than females,
and older maternal age at time of delivery is associated
with an increased risk of food allergy diagnosis in off-
spring. These demographic associations could be asso-
ciated with disruptions in acquisition of gut flora and
are worthy of further exploration. It is conceivable that
male neonates born to older mothers might benefit the
most from early intervention with probiotic therapies,
but this remains to be explored.
Additional File
Additional file 1: Figure S1. In vitro Coincubation. De-identified PBMCs
(2 × 106 cells/mL) were collected from 6 healthy adult donors and 6 cord
blood donors (IRB oversight #36219NHR and #33295NHR) and
co-incubated with lactobacilli and bifidobacteria for 24 hours according
to the method described by Foligne et al (reference below). Significant
increases in mean levels of (A) IFN-γ (p=0.004), (C) IL-10 (p=0.001), and
(E) IL-12 (p=0.001) and were observed following co-incubation of
adult-derived cells. Cord blood-derived PBMCs exposed to the bacterial
cocktail nearly doubled (B) IFN-γ secretion (p=0.03), (D) increased IL-10
(p=0.001) secretion by 130-fold, (F) but did not lead to substantial
changes in IL-12 secretion (2.69 ±2.35 pg/mL to 2.85 ±1.91 pg/mL;
p=0.40). Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D,
Poiret S, Dewulf J, Brassert D, Mercenier A, Pot B: Correlation between
in vitro and in vivo immunomodulatory properties of lactic acid
bacteria. World J Gastroenterol 2007, 13:236-243.
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